Name: Harbin Gloria Pharmaceuticals Co. Ltd. - BioCentury Company Profiles - BCIQ
Creator: Biocentury

signInButton

SIGN IN

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Please note, you are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. Request a trial to unlock the full value of BCIQ.

REQUEST A FREE TRIAL

AcquiredOrMerged

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.

If you believe a company has been archived in error, please contact us at 

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.\nIf you believe a company has been archived in error, please contact us at \nsupport@biocentury.com\n.

Cat-H(AcquiredorMerged)

Historical deals and financings can be found by searching the organization's name in the BCIQ <DEALS> and <FINANCING> Modules.

Default (Company Type Blank)

CategoryHDefault (Company Type Blank)

NonBioPharma

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.

Cat-H(NonBioPharma)

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.\n

Harbin Gloria Pharmaceuticals Co. Ltd.

GenFleet eyes proof of concept with $50M series B

After Ally Bridge-backed series A, Shanghai's GenFleet looks to clinic

After Ally Bridge-backed series A, Shanghai's GenFleet looks to clinic

Harbin Gloria selling stake in biotech unit to new investors

Harbin Gloria selling stake in biotech unit

Arcus reports Phase I safety data for cancer candidate AB928

Arcus raises upsized $120M IPO

Modest first-day pop for Arcus after upsized $120M IPO

Immuno-oncology play Arcus raises $107M

Immuno-oncology play Arcus raises $107M